Brought to you by 
Purdue, Mundipharma, Infinity in major oncology/pain deal; relationship ends
03 Nov 2016
Executive Summary
Purdue Pharma LP and its European affiliate Mundipharma International have entered into a multi-faceted development and co-commercialization partnership with Infinity Pharmaceuticals (cancer therapeutics). The agreement gives Infinity freedom to work on its pipeline while securing steady cash flow through 2013.
Deal Industry
- Biotechnology
- Pharmaceuticals
Deal Status
- Terminated
Deal Type
-
Alliance
- Includes Equity
- Includes Royalty or Profit Split Information
- R&D and Marketing (Licensing)
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com